Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
E
Eckelman, Brendan
Inhibrx, Inc
(
P 041
)
UPDATED EFFICACY AND SAFETY OF THE TETRAVALENT DEATH RECEPTOR 5 AGONIST INBRX-109 IN PATIENTS WITH CHONDROSARCOMA: DATA FROM THE PHASE 1 EXPANSION COHORTS
Brendan Eckelman
Favorite
(
P 315
)
A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL OF INBRX-109 IN UNRESECTABLE OR METASTATIC CONVENTIONAL CHONDROSARCOMA
Brendan Eckelman
Favorite
(
P 317
)
INBRX-109 IN EWING SARCOMA: PRECLINICAL RATIONALE FOR INITIATION OF A PHASE 1 CHEMOTHERAPY COMBINATION EXPANSION COHORT
Brendan Eckelman
Favorite
Efficace, Fabio
GIMEMA Foundation
(
P 319
)
PATIENT REPORTED OUTCOME ASSESSMENT AND REPORTING IN RANDOMIZED CLINICAL TRIALS OF SYSTEMIC THERAPY FOR ADVANCED SOFT TISSUE SARCOMAS; PROTOCOL FOR A SYSTEMATIC REVIEW
Fabio Efficace
Favorite
Eich, Hans
Radiotherapy and Radiooncology, University Hospital Muenster, West German Cancer Center Network,
(
P 042
)
VALUE OF ADJUVANT RADIOTHERAPY IN PATIENTS WITH LOCALIZED EWING SARCOMA AT THE EXTREMITIES. REPORT FROM THE EWING 2008 TRIAL
Hans Eich
Favorite
Eilber, Fritz
UCLA Health
(
P 173
)
DYSREGULATION OF MITOCHONDRIAL DYNAMICS IN WELL-DIFFERENTIATED/DEDIFFERENTIATED LIPOSARCOMA PROVIDES A UNIQUE SUSCEPTABILITY TO NOVEL THERAPY
Fritz Eilber
Favorite
(
P 184
)
PAN-SARCOMA ORGANOID SCREENING PIPELINE
Fritz Eilber
Favorite
Eiseler, Nicole
Miami Cancer Institute
(
P 309
)
THE ONCOLOGY ORTHOPEDIST ROLE: WHERE DO WE FIT?
Nicole Eiseler
Favorite
Ek, Torben
Childhood Cancer Center Queen Silvia Children´s Hospital
(
P 042
)
VALUE OF ADJUVANT RADIOTHERAPY IN PATIENTS WITH LOCALIZED EWING SARCOMA AT THE EXTREMITIES. REPORT FROM THE EWING 2008 TRIAL
Torben Ek
Favorite
El Zein, Sophie
Department of Biopathology, Institut Curie, Paris Sciences et Lettres Research University
(
P 189
)
PROGNOSTIC IMPACT OF NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA-1 EXPRESSION AND HUMAN LEUKOCYTE ANTIGEN SUBTYPES IN METASTATIC SYNOVIAL SARCOMA
Sophie El Zein
Favorite
Elefant, Erica
Adaptimmune
(
P 127
)
IDENTIFYING MAGE-A4-POSITIVE TUMORS FOR SPEAR T-CELL THERAPIES IN HLA-A*02-ELIGIBLE PATIENTS
Erica Elefant
Favorite
Eleftheriadou, Ioanna
Head of Oncology Cell Therapy Clinical Biomarkers, GSK
(
P 189
)
PROGNOSTIC IMPACT OF NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA-1 EXPRESSION AND HUMAN LEUKOCYTE ANTIGEN SUBTYPES IN METASTATIC SYNOVIAL SARCOMA
Ioanna Eleftheriadou
Favorite
Elgenaidi, Ismail
Trinity translational Medicine Institute
(
P 235
)
ELUCIDATING THE ONCOGENIC EFFECT OF BCOR-ITD IN SARCOMA
Ismail Elgenaidi
Favorite
El-Heliebi, Amin
Center for Biomarker Research in Medicine (CBmed)
(
P 141
)
TUMOUR-INFILTRATING IMMUNE CELLS IN SOFT TISSUE SARCOMA. IMPACT ON LOCAL RECURRENCE, DISTANT METASTASIS, AND OVERALL SURVIVAL.
Amin El-Heliebi
Favorite
Elhossiny, Ahmed
University of Michigan
(
P 139
)
T-CELL PROFILING IN HIGH GRADE SARCOMAS
Ahmed Elhossiny
Favorite
Elias, Anthony
University of Colorado Cancer Center
(
P 312
)
A PHASE 1/2 STUDY OF CFT8634, A NOVEL BIFUNCTIONAL DEGRADATION ACTIVATING COMPOUND (BIDAC) DEGRADER OF BRD9, IN SYNOVIAL SARCOMA AND SMARCB1-NULL TUMORS
Anthony Elias
Favorite
Ellegast, Jana
Dana Farber
(
P 036
)
STAG2 LOSS ENCHANCES SENSITIVITY TO DNA DAMAGE YET REDUCES DNA DAMAGE-INDUCED INFLAMMATION IN EWING SARCOMA
Jana Ellegast
Favorite
Elliott, Andrew
Caris Life Science
(
P 234
)
DNA DAMAGE RESPONSE PATHWAYS IN SYNOVIAL SARCOMA
Andrew Elliott
Favorite
Elmi Assadzadeh, Golpira
University of Calgary
(
P 205
)
PREOPERATIVE CHEMORADIATION (MODIFIED EILBER PROTOCOL) VERSUS NEOADJUVANT/ ADJUVANT RADIOTHERAPY FOR SOFT TISSUE EXTREMITY SARCOMAS: A POPULATION BASED ANALYSIS IN ALBERTA
Golpira Elmi Assadzadeh
Favorite
Elnekave, Eldad
Shaare Tzedek Medical Center
(
P 257
)
SELECTIVE INTRA-ARTERIAL DOXORUBICIN-ELUTING EMBOLIZATION FOR DESMOID FIBROMATOSIS: A COMBINED PROSPECTIVE AND RETROSPECTIVE STUDY
Eldad Elnekave
Favorite
Elvin, Julia
Foundation Medicine Inc.
(
P 256
)
TUMOR MUTATIONAL BURDEN AND MICROSATELLITE INSTABILITY IN LEIOMYOSARCOMA
Julia Elvin
Favorite
Emori, Maoto
Sapporo Medical University School of Medicine
(
P 084
)
PROGNOSTIC FACTORS IN PATIENTS WITH DISTANT SOFT TISSUE METASTASIS OF CARCINOMA
Maoto Emori
Favorite
(
P 285
)
IMPACT OF ACRIDINE ORANGE IN PATIENTS WITH LOCAL RECURRENT SOFT TISSUE SARCOMA
Maoto Emori
Favorite
Encarnación, Juan Antonio
HCU VIRGEN ARRIXACA
(
P 318
)
NEOADJUVANT CHEMORADIOTHERAPY IN ADVANCED SOFT TISSUE SARCOMA. UPDATED NASAR STUDY
Juan Antonio Encarnación
Favorite
Encinas, Victor
Hospital Universitario Virgen del Rocío
(
P 267
)
EFFICACY OF SORAFENIB IN PRETREATED DESMOID TUMORS. EXPERIENCE OF A HIGH-VOLUME CENTER.
Victor Encinas
Favorite
Endo, Makoto
Kyushu University Department of Orthopaedic Surgery
(
P 125
)
EFFECTIVENESS OF PERIPHERAL BLOOD IMMUNE-RELATED MARKERS IN SELECTING NOVEL THERAPEUTIC AGENTS FOR ADVANCED SOFT TISSUE SARCOMA
Makoto Endo
Favorite
Engelmann, Bodil
Department of Oncology, Copenhagen University Hospital at Herlev
(
P 120
)
THE DIAGNOSTIC AND PROGNOSTIC VALUE OF PLASMA SMALL EXTRACELLULAR VESICLES PHENOTYPE IN PATIENTS WITH GASTROINTESTINAL STROMAL TUMOUR
Bodil Engelmann
Favorite
England, Patrick
Washington University in St. Louis
(
P 075
)
EXAMINING PATIENT PERSPECTIVES ON SARCOMA SURVEILLANCE: THE SARCOMA SURVEILLANCE SURVEY
Patrick England
Favorite
Entz-Werle, Natacha
CHU Strasbourg
(
P 026
)
IS THERE STILL A PLACE FOR BONE MARROW SAMPLING IN VERY HIGH RISK EWING SARCOMA? ROLE OF FDG PET/CT IN THE INITIAL STAGING OF VERY HIGH RISK EWING SARCOMA IN A PROSPECTIVE PHASE II MULTICENTRIC STUDY.
Natacha Entz-Werle
Favorite
Erinjeri, Joseph
Memorial Sloan Kettering Cancer Center
(
P 134
)
PHASE II STUDY OF RUCAPARIB AND NIVOLUMAB IN PATIENTS WITH LEIOMYOSARCOMA
Joseph Erinjeri
Favorite
(
P 257
)
SELECTIVE INTRA-ARTERIAL DOXORUBICIN-ELUTING EMBOLIZATION FOR DESMOID FIBROMATOSIS: A COMBINED PROSPECTIVE AND RETROSPECTIVE STUDY
Joseph Erinjeri
Favorite
Ernest, Emily
Nationwide Children's Hospital
(
P 027
)
LEPTOMENINGEAL ENHANCEMENT WITH NEUROLOGIC CHANGES IN PEDIATRIC BONE SARCOMA PATIENTS: A DIAGNOSTICAL CHALLENGE
Emily Ernest
Favorite
Escande, Alexandre
Centre Oscar Lambret
(
P 080
)
INTRACRANIAL SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA MANAGEMENT: A FRENCH MULTICENTRE RETROSPECTIVE STUDY
Alexandre Escande
Favorite
Espejo Freire, Andrea
University of Miami
(
P 07
)
HETEROGENEITY IN TREATMENT REGIMENS FOR AYA BONE SARCOMAS: A COMPARISON OF OUTCOMES AT A SINGLE SARCOMA CENTER
Andrea Espejo Freire
Favorite
Espejo, Andrea
University of Minnesota
(
P 263
)
COMPARATIVE EFFECTIVENESS OF SYSTEMIC TREATMENTS IN DESMOID TUMORS
Andrea Espejo
Favorite
Espejo-Freire, Andrea
University of Miami/Sylvester Comprehensive Cancer Center
(
P 070
)
COMPLETE PATHOLOGICAL RESPONSE AFTER NEOADJUVANT TREATMENT IN SOFT TISSUE SARCOMA. A SINGLE INSTITUTION EXPERIENCE.
Andrea Espejo-Freire
Favorite
(
P 234
)
DNA DAMAGE RESPONSE PATHWAYS IN SYNOVIAL SARCOMA
Andrea Espejo-Freire
Favorite
Estival, Anna
Institut Catalá d'Oncologia
(
P 161
)
PALBOSARC: A PHASE II TRIAL OF PALBOCICLIB IN ADVANCED SARCOMA OVEREXPRESSING CDK4 GENE EXCLUDING DEDIFFERENTIATED LIPOSARCOMA (DD LPS): A STUDY FROM THE SPANISH GROUP FOR RESEARCH ON SARCOMA (GEIS).
Anna Estival
Favorite
eunseok, choi
Chungnam National University, School of Medicine, Dept. of Orthopaedic Surgery
(
P 228
)
CHARACTERIZING ORGANELLES IN MYXOFIBROSARCOMA CELLS USING LABEL-FREE OPTICAL DIFFRACTION TOMOGRAPHY
choi eunseok
Favorite
Evans, Abigail
Euro Ewing Consortium
(
P 148
)
ANALYSIS OF REECUR TRIAL DATA TO EVALUATE POTENTIAL PROGNOSTIC FACTORS IN RECURRENT AND PRIMARY REFRACTORY EWING SARCOMA (RR-ES)
Abigail Evans
Favorite
Eward, William
Department of Orthopedic Surgery, Duke University
(
P 034
)
REGIONAL ANESTHESIA IMPROVES METASTASIS FREE SURVIVAL AFTER SURGICAL RESECTION OF BONE SARCOMAS
William Eward
Favorite
(
P 171
)
CANINE-DERIVED OSTEOSARCOMA ORGANOIDS MODEL TUMOR HETEROGENEITY AND CHEMOTHERAPY RESISTANCE
William Eward
Favorite
(
P 288
)
LOCKING PLATE AUGMENTATION OF POLYMETHYLMETHACRYLATE-FILLED DISTAL FEMUR DEFECTS
William Eward
Favorite
Exter, Benjamin
Cogent Biosciences
(
P 320
)
PEAK STUDY: A PHASE 3 RANDOMIZED, OPEN-LABEL, MULTICENTER CLINICAL STUDY OF BEZUCLASTINIB (CGT9486) AND SUNITINIB VERSUS SUNITINIB IN PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS
Benjamin Exter
Favorite
Eyles, Sarah
Rush University Medical Center
(
P 032
)
PLEURAL RELAPSE OF OSTEOSARCOMA AFTER TALC PLEURODESIS
Sarah Eyles
Favorite
Back to Top
